SP, page-13

Reading Rick’s most recent presentation it seems a few products aren’t too far off trials. I think the market is also missing the testing/research services the co is providing which can provide solid revenue streams.

I have been closely watching the trading this year and it’s all off screen stuff. The top 20 are just swapping shares.

Also the board and instos are still topping up.

The term ‘inflection point’ gets thrown around a lot but I believe UBI is there.